SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PHCC Priority Healthcare
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RockyBalboa who wrote (21)1/23/2001 9:25:45 PM
From: blebovits  Read Replies (1) of 103
 
Priority Healthcare Reiterated N-T `Accumulate' at Merrill
By Michael O. Donohue

Princeton, New Jersey, Jan. 22 (Bloomberg Data) -- Priority Healthcare Corp (PHCC US) was reiterated near-term ``accumulate'' by analyst David R. Risinger at Merrill Lynch. The 12-month target price is $38.00 per share. The long-term rating was reiterated ``buy.''

quote.bloomberg.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News